CXCL13 chemokine in pediatric and adult neuroborreliosis
Source: Acta Neurologica Scandinavica, Volume 124, Number 5, 1 November 2011 , pp. 321-328(8)
Abstract:Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E. CXCL13 chemokine in pediatric and adult neuroborreliosis. Acta Neurol Scand: 2011: 124: 321–328. © 2011 John Wiley & Sons A/S.
Objectives – Diagnosis of Lyme neuroborreliosis (NB) depends on the proof of intrathecal antibody production against Borrelia burgdorferi. CXCL13 has been seen to be elevated early in NB, before antibody production has started. In this study, we determined the diagnostic role of the CXCL13 chemokine in cerebrospinal fluid (CSF) and serum for the first time in pediatric NB patients as well as in adults, compared to controls and blood donors (BD).
Material and methods – CXCL13 levels were measured in CSF and serum of 33 children and 42 adult patients. Serum CXCL13 was measured in 300 BD.
Results – CSF CXCL13 levels were significantly elevated in definite and probable acute NB in children and adults compared to seropositive and seronegative neurological controls (P < 0.001). Serum CXCL13 levels showed great fluctuations and were not significantly elevated in NB patients.
Conclusions – Our study suggests that CSF CXCL13 can be used as a diagnostic marker for NB in children as well. In contrast, CXCL13 serum levels show great variance even in the healthy population and are not indicative of active NB.
Document Type: Research Article
Affiliations: 1: Department of Dermatology 2: Institute for Medical Informatics, Statistics and Documentation 3: Department of General Pediatrics 4: Institute for Hygiene and Microbiology 5: Department of Neurology, Medical University of Graz, Graz, Austria
Publication date: November 1, 2011